Nuformix plc (LON:NFX – Get Free Report) was up 25.3% during trading on Wednesday . The stock traded as high as GBX 0.28 ($0.00) and last traded at GBX 0.24 ($0.00). Approximately 299,087,469 shares were traded during trading, an increase of 456% from the average daily volume of 53,816,531 shares. The stock had previously closed at GBX 0.19 ($0.00).
Nuformix Stock Up 0.4%
The stock has a market cap of £4.00 million, a price-to-earnings ratio of -59.00 and a beta of 1.22. The company has a 50 day simple moving average of GBX 0.11 and a 200 day simple moving average of GBX 0.11.
Nuformix Company Profile
Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis.
Recommended Stories
- Five stocks we like better than Nuformix
- How to buy stock: A step-by-step guide for beginners
- General Dynamics Hits New Highs: Why It Might Keep Climbing
- Overbought Stocks Explained: Should You Trade Them?
- Nike’s Turnaround: If the Shoe Fits, Buy It!
- NYSE Stocks Give Investors a Variety of Quality Options
- NVIDIA Breaks Out to New Highs: What Comes Next?
Receive News & Ratings for Nuformix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nuformix and related companies with MarketBeat.com's FREE daily email newsletter.
